X4 Pharmaceuticals Statistics

Total Valuation

XFOR has a market cap or net worth of $169.62 million. The enterprise value is $147.02 million.

Market Cap	169.62M
Enterprise Value	147.02M

Important Dates

The last earnings date was Tuesday, May 7, 2024, before market open.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

XFOR has 167.94 million shares outstanding. The number of shares has increased by 37.01% in one year.

Shares Outstanding	167.94M
Shares Change (YoY)	+37.01%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	0.94%
Owned by Institutions (%)	67.60%
Float	128.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	6.77
PB Ratio	163.72
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.71, with a Debt / Equity ratio of 56.25.

Current Ratio	3.71
Quick Ratio	3.47
Debt / Equity	56.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.69

Financial Efficiency

Return on equity (ROE) is -275.40% and return on invested capital (ROIC) is -195.09%.

Return on Equity (ROE)	-275.40%
Return on Assets (ROA)	-85.10%
Return on Capital (ROIC)	-195.09%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, XFOR has paid $93,000 in taxes.

Income Tax	93,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.25% in the last 52 weeks. The beta is 0.51, so XFOR's price volatility has been lower than the market average.

Beta (1Y)	0.51
52-Week Price Change	-50.25%
50-Day Moving Average	1.17
200-Day Moving Average	0.98
Relative Strength Index (RSI)	48.97
Average Volume (30 Days)	3,327,517

Short Selling Information

The latest short interest is 12.21 million, so 7.27% of the outstanding shares have been sold short.

Short Interest	12.21M
Short Previous Month	13.19M
Short % of Shares Out	7.27%
Short % of Float	9.53%
Short Ratio (days to cover)	2.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-115.71M
Pretax Income	-128.82M
Net Income	-128.91M
EBITDA	-120.35M
EBIT	-122.28M
Earnings Per Share (EPS)	-$0.69

Full Income Statement

Balance Sheet

The company has $80.87 million in cash and $58.28 million in debt, giving a net cash position of $22.59 million or $0.13 per share.

Cash & Cash Equivalents	80.87M
Total Debt	58.28M
Net Cash	22.59M
Net Cash Per Share	$0.13
Equity / Book Value	1.04M
Book Value Per Share	0.01
Working Capital	63.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$103.60 million and capital expenditures -$110,000, giving a free cash flow of -$103.71 million.

Operating Cash Flow	-103.60M
Capital Expenditures	-110,000
Free Cash Flow	-103.71M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XFOR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.01%
Shareholder Yield	-37.01%
Earnings Yield	-76.00%
FCF Yield	-61.14%

Analyst Forecast

The average price target for XFOR is $3.67, which is 263.37% higher than the current price. The consensus rating is "Buy".

Price Target	$3.67
Price Target Difference	263.37%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 14, 2019. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 14, 2019
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1